A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial

Peer Review reports

Original Submission
2 Dec 2016	Submitted	Original manuscript
25 Apr 2017	Reviewed	Reviewer Report - Kathrin Eller
3 May 2017	Author responded	Author comments - Theodoros Kassimatis
Resubmission - Version 2
3 May 2017	Submitted	Manuscript version 2
Publishing
5 May 2017	Editorially accepted
6 Jun 2017	Article published	10.1186/s13063-017-1972-x

Back to article page